Related references
Note: Only part of the references are listed.Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination
Michael Kongsgaard et al.
SCIENTIFIC REPORTS (2017)
Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine
Huabin Liang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Booster dose after 10 years is recommended following 17DD-YF primary vaccination
Ana Carolina Campi-Azevedo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Yellow fever vaccine: worthy friend or stealthy foe?
Stephen J. Seligman et al.
EXPERT REVIEW OF VACCINES (2016)
Fractional dosing of yellow fever vaccine to extend supply: a modelling study
Joseph T. Wu et al.
LANCET (2016)
Yellow fever vaccine-associated viscerotropic disease: current perspectives
Roger E. Thomas
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+but not CD8+T Cells
Alan M. Watson et al.
PLOS PATHOGENS (2016)
Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia
Ed Clarke et al.
LANCET GLOBAL HEALTH (2016)
A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination
Rosanne W. Wieten et al.
PLOS ONE (2016)
Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali
Panchali Roy Chowdhury et al.
CLINICAL INFECTIOUS DISEASES (2015)
Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans
Axel Ronald Schulz et al.
JOURNAL OF IMMUNOLOGY (2015)
A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination
Rama S. Akondy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
Renata C. Pereira et al.
VACCINE (2015)
Serious adverse events associated with yellow fever vaccine
Reinaldo de Menezes Martins et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
A DNA Vaccine against Yellow Fever Virus: Development and Evaluation
Milton Maciel et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever
Ana C. V. Oliveira et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
Saranya Sridhar et al.
VACCINES (2015)
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
Ana Carolina Campi-Azevedo et al.
BMC INFECTIOUS DISEASES (2014)
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine
Enoch Muyanja et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Yellow Fever Outbreaks in Unvaccinated Populations, Brazil, 2008-2009
Alessandro Pecego Martins Romano et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Review Article: Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years
Eduardo Gotuzzo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Immunity to viruses: learning from successful human vaccines
Bali Pulendran et al.
IMMUNOLOGICAL REVIEWS (2013)
Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type Response
Kim Blom et al.
JOURNAL OF IMMUNOLOGY (2013)
Yellow Fever Vaccination Elicits Broad Functional CD4+ T Cell Responses That Recognize Structural and Nonstructural Proteins
Eddie A. James et al.
JOURNAL OF VIROLOGY (2013)
Early IFN-Gamma Production after YF 17D Vaccine Virus Immunization in Mice and Its Association with Adaptive Immune Responses
Patricia C. C. Neves et al.
PLOS ONE (2013)
Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more
Karina Takesaki Miyaji et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
17DD yellow fever vaccine A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study
Reinaldo M. Martins et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Dissection of Antibody Specificities Induced by Yellow Fever Vaccination
Oksana Vratskikh et al.
PLOS PATHOGENS (2013)
The Safety of Yellow Fever Vaccine 17D or 17DD in Children, Pregnant Women, HIV+ Individuals, and Older Persons: Systematic Review
Roger E. Thomas et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Detection of Anti-Yellow Fever Virus Immunoglobulin M Antibodies at 3-4 Years Following Yellow Fever Vaccination
Katherine B. Gibney et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
The early cellular signatures of protective immunity induced by live viral vaccination
Siegfried Kohler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Review of the risks and benefits of yellow fever vaccination including some new analyses
Thomas P. Monath
EXPERT REVIEW OF VACCINES (2012)
Plasma HIV-RNA Is the Key Determinant of Long-Term Antibody Persistence After Yellow Fever Immunization in a Cohort of 364 HIV-Infected Patients
Jerome Pacanowski et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated Children
Ana Carolina Campi-Azevedo et al.
PLOS ONE (2012)
Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study
L. S. Azevedo et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Description of a Prospective 17DD Yellow Fever Vaccine Cohort in Recife, Brazil
Andrea Barbosa de Melo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Insights into human CD8+ T-cell memory using the yellow fever and smallpox vaccines
Rafi Ahmed et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Cytokine Signatures of Innate and Adaptive Immunity in 17DD Yellow Fever Vaccinated Children and Its Association With the Level of Neutralizing Antibody
Maria Luiza-Silva et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
An Inactivated Cell-Culture Vaccine against Yellow Fever
Thomas P. Monath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia following Yellow Fever Vaccination: A Prospective Controlled Cohort Study
Anna H. Roukens et al.
PLOS ONE (2011)
Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults
Maria Luiza Silva et al.
VACCINE (2011)
Clinical and Immunological Insights on Severe, Adverse Neurotropic and Viscerotropic Disease following 17D Yellow Fever Vaccination
Maria Luiza Silva et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Yellow Fever: A Reemerging Threat
Christina L. Gardner et al.
CLINICS IN LABORATORY MEDICINE (2010)
CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5-7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses
Patricia C. C. Neves et al.
VACCINE (2010)
Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity
Thomas P. Monath et al.
VACCINE (2010)
Pathways of memory CD8+ T-cell development
Oliver Bannard et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
Rama S. Akondy et al.
JOURNAL OF IMMUNOLOGY (2009)
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Troy D. Querec et al.
NATURE IMMUNOLOGY (2009)
TLR expression and NK cell activation after human yellow fever vaccination
Patricia Cristina da Costa Neves et al.
VACCINE (2009)
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: Implications for vaccine development
Theodore C. Pierson et al.
CELL HOST & MICROBE (2008)
Yellow fever: 100 years of discovery
J. Erin Staples et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Denis Gaucher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes
Bali Pulendran et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Pressure-inactivated yellow fever 17DD virus:: Implications for vaccine development
Luciane P. Gaspar et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination
Marina Angela Martins et al.
VACCINE (2008)
Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccine
Erling Norrby
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections
Christina A. Scherer et al.
VACCINE (2007)
Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: Implications for the Brazilian National Immunization Program
Luiz Antonio Bastos Camacho et al.
VACCINE (2007)
Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?
M. A. Martins et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial
LAB Camacho et al.
REVISTA DE SAUDE PUBLICA (2005)
Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus
AP dos Santos et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2005)
Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial
LAB Camacho et al.
REVISTA DE SAUDE PUBLICA (2004)
Comparative safety and immunogenicity of two yellow fever 17D vaccines (Arilvax and YF-VAX) in a Phase III multicenter, double-blind clinical trial
TP Monath et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Share Paper
